Current opinion in obstetrics & gynecology, 14(3), 293-294, 2002
What to do about the polycystic ovary 'epidemic'
Author affiliations
- MRC Centre for Reproductive Health ROR
Abstract
University department of Obstetrics and Gynaecology, Jessop Wing, Sheffield Correspondence to Professor William Ledger, Head of Reproductive Medicine,
Topics
polycystic ovary syndrome epidemic prevalence, PCOS diagnosis overdiagnosis controversy, polycystic ovary management clinical opinion, PCOS diagnostic criteria Rotterdam NIH, polycystic ovary ultrasound prevalence population, Thacher PCOS editorial opinion, PCOS treatment guidelines review, polycystic ovary syndrome clinical management debate, increasing PCOS diagnosis rates women
PMID 12032385 12032385 DOI 10.1097/00001703-200206000-00008 10.1097/00001703-200206000-00008
Cite this article
Thacher, S. S. (2002). What to do about the polycystic ovary 'epidemic'. Current opinion in obstetrics & gynecology, 14(3), 293-294. https://doi.org/10.1097/00001703-200206000-00008
Thacher SS. What to do about the polycystic ovary 'epidemic'. Curr Opin Obstet Gynecol. 2002;14(3):293-294. doi:10.1097/00001703-200206000-00008
Thacher, S. S. "What to do about the polycystic ovary 'epidemic'." Current opinion in obstetrics & gynecology, vol. 14, no. 3, 2002, pp. 293-294.
Related articles
PCOSDiagnostic CriteriaHyperandrogenismAndrogen Levels
Do hyperandrogenic women with normal menses have polycystic ovary syndrome?
Carmina E et al., 1999·Fertil Steril
To determine the prevalence of polycystic ovary syndrome (PCOS) among hyperandrogenic women who report normal menses. Prospective observational study. Academic practice in reproductive endocrinology. PATIENT(S): Fifty-eight consecutively seen new patients with hyperandrogenism who reported normal menses. INTERVENTION(S): Ovulatory status was assessed with timed serum progesterone measurements. The following vaginal ultrasound examination; measurement of the ovarian response of 17-hydroxyprogesterone (17-OHP) after the administration of leuprolide acetate, 1 mg SC; and determination of fasting serum LH, FSH, E2, 17-OHP, insulin, and androgen levels. MAIN OUTCOME MEASURE(S): Determination of ovulatory status, polycystic appearance of ovaries, and increased response of 17-OHP to leuprolide acetate. RESULT(S): Twelve (20.7%) of the hyperandrogenic women were anovulatory and met the usual criteria for the diagnosis of PCOS. The ovulatory patients had lower serum total and unbound testosterone levels. Thirty-one (53.4%) of the ovulatory women had polycystic ovaries on ultrasound examination and/or an increased 17-OHP response to leuprolide acetate, suggesting the diagnosis of PCOS despite the presence of ovulation. Considering both the anovulatory and ovulatory patients, 74% of the hyperandrogenic women studied could have PCOS. CONCLUSION(S): The data suggest that most (74%) hyperandrogenic women who report normal menses have evidence for the diagnosis of PCOS.
Research
Non-hormonal mediators of uterine fibroid growth
Cetin E et al., 2020·Current opinion in obstetrics & gynecology
Uterine fibroids are the most common benign neoplasms of the female reproductive tract and one of the major public health concerns. Although most women with uterine fibroids are asymptomatic, over 30% of them will present with varying symptoms. This review focuses on the role of non-hormonal mediators and pathways in uterine fibroid biology. Furthermore, it provides data regarding the most recent findings in the field of compounds, which use those non-hormonal pathways in the medical therapy of uterine fibroids. Complex signaling pathway alterations are crucial for uterine fibroid development. The topic of the pathophysiology of uterine fibroids focuses mostly on steroids and other hormones. However, other very important pathways exist, and some of them are independent of hormones. Some of the most important pathways, which are non-hormonal, but in some cases still hormone-depended, include growth factors, cytokines and inflammation, Smad proteins, wingless type/β-catenin and others. Much more is known about hormonal than about non-hormonal signaling in uterine fibroids. Growth factors, early life exposure and inflammation are key factors in uterine fibroid biology. Numerous agents depend on those pathways and may find their place in the current and future therapy of uterine fibroids.
Research
Oocyte mitochondrial function and reproduction
Babayev E et al., 2015·Current opinion in obstetrics & gynecology
Mitochondria are cellular organelles that are required for energy production. Emerging evidence demonstrates their role in oocyte development and reproduction. In this review, we examine recent animal and clinical studies on the role of mitochondria in fertility. We also analyse the impact of assisted reproductive techniques (ARTs) on mitochondrial function and discuss the future clinical implications of mitochondrial nutrients and mitochondrial replacement. Mitochondria affect all aspects of mammalian reproduction. They are essential for optimal oocyte maturation, fertilization and embryonic development. Mitochondrial dysfunction causes a decrease in oocyte quality and interferes with embryonic development. ART procedures affect mitochondrial function, while mitochondrial nutrients may increase mitochondrial performance in oocytes. New mitochondrial replacement procedures using mitochondria obtained from polar bodies or from the patient's own oogonial stem cells are promising and may address concerns related to the induction of high-levels of heteroplasmy, which could potentially result in negative long-term health effects. Optimal energy production is required for oocyte and embryo development, and mitochondrial abnormalities have devastating reproductive consequences. Improvement of oocyte mitochondrial function via intake of compounds that boost mitochondrial activity may have clinical benefits, and mitochondrial replacement could potentially be used for the prevention of mitochondrial diseases.
SurgeryIsthmocele RepairCesarean Scar DefectLong-Term Complications
Hysteroscopic treatment of the cesarean-induced isthmocele in restoring infertility
Florio P et al., 2012·Curr Opin Obstet Gynecol
To review the treatments of the cesarean-induced isthmocele in restoring infertility, associated techniques, and the risks of complications associated with their use. Isthmocele is a reservoir-like pouch defect on the anterior wall of the uterine isthmus located at the site of a previous cesarean delivery scar. The flow of menstrual blood through the cervix may be slowed by the presence of isthmocele, as the blood may accumulate in the niche because of the presence of fibrotic tissue, causing pelvic pain in the suprapubic area. Moreover, persistence of the menstrual blood after menstruation in the cervix may negatively influence the mucus quality and sperm quality, obstruct sperm transport through the cervical canal, interfere with embryo implantation, leading to secondary infertility. The removal of the local inflamed tissue may be performed by laparoscopic, combined laparoscopic-vaginal, or vaginal surgery, and operative hysteroscopy, a minimally invasive approach to improve symptoms and restore fertility. Isthmocele occurs after cesarean section, a common method of delivery and one of the most frequent surgical procedures, so that its upward incidence appears likely to continue in the near future. Because of its minimal invasiveness, resectoscopy may be the better choice for treatment, yielding good therapeutic results.